A Feasibility Study of AlzLife 40 Hz Sensory Therapy in Patients with MCI and Early AD

Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI) are debilitating diseases that affect millions of individuals and have notoriously limited treatment options. One emerging therapy, non-invasive 40 Hz sensory therapy delivered through light and sound has previously shown promise in improv...

Descripción completa

Detalles Bibliográficos
Autores principales: McNett, Sienna D., Vyshedskiy, Andrey, Savchenko, Andrei, Durakovic, Danijel, Heredia, George, Cahn, Rael, Kogan, Mikhail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379682/
https://www.ncbi.nlm.nih.gov/pubmed/37510481
http://dx.doi.org/10.3390/healthcare11142040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379682/
https://www.ncbi.nlm.nih.gov/pubmed/37510481
http://dx.doi.org/10.3390/healthcare11142040

Ejemplares similares